Pharma & Biotech
Imugene presents HER2 immuno-oncology vaccines success at ESMO ahead of 2020 studies
GSRX Industries is smoking hot as its dispensaries and CBD products generate strong revenue
Kazia Therapeutics studies evaluate therapeutic candidates in ovarian cancer and brain tumours
Only registered members can use this feature.
Copyright © Proactive Investors 2019.
All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC.